Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,551 total articles

Algorhythm Expands Executive Team

Algorhythm Expands Executive Team

Algorhythm Holdings, Inc., a diversified holding company owning renewable energy developer Azure Energy and AI logistics provider SemiCab, announced key executive leadership changes, including the appointment of Andrew Thompson as CEO, Ryan Smith as COO, and Leticia Raele as Chief Accounting Officer and Interim CFO. These appointments coincide with…

Elevra Lithium 2026 Annual General Meeting Information

Elevra Lithium 2026 Annual General Meeting Information

Elevra Lithium Limited, a North American lithium producer listed on ASX and NASDAQ, has announced key dates for its 2026 Annual General Meeting, including director nominations and the release of the Notice of Meeting. Shareholders will receive information on participation closer to the meeting date.

LPL Financial Welcomes Lakewood Wealth Management

LPL Financial Welcomes Lakewood Wealth Management

LPL Financial has announced that the financial advisors from Lakewood Wealth Management have joined its broker-dealer and Registered Investment Advisor platforms. The Lakewood team brings approximately $170 million in assets under management. The move enhances LPL's advisory capabilities and provides Lakewood's clients with access to LPL's technolo…

Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility

Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility

Silo Pharma, a US-based developmental-stage biopharmaceutical company, announced enhancements to its AI agent subsidiary QwikAgents' platform by incorporating support for NVIDIA Nemotron models and introducing a new Hermes agent runtime alongside the existing OpenClaw runtime. These updates provide customers greater flexibility in AI model and soft…

SUNation Founder and CEO Scott Maskin to Speak at HIA-LI Energy Conference on Renewable Adoption and Policy Challenges

SUNation Founder and CEO Scott Maskin to Speak at HIA-LI Energy Conference on Renewable Adoption and Policy Challenges

SUNation Energy Inc. announced that CEO Scott Maskin will speak at the HIA-LI Energy Conference focusing on the increasing electricity demand, new state energy policies including renewable requirements for new buildings, and opportunities for distributed energy resources. The company's leadership involvement highlights growth prospects amid evolvin…

Beacon Financial Corporation Announces Third Quarter 2026 Earnings Release Date and Conference Call

Beacon Financial Corporation Announces Third Quarter 2026 Earnings Release Date and Conference Call

Beacon Financial Corporation (NYSE: BBT), a regional bank based in Boston with $22.3 billion in assets, announced it will release its third quarter 2026 earnings on October 21, 2026, followed by a management conference call on October 22, 2026. The company provides a wide range of banking services across New England and New York, including commerci…

Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab

Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab

Q/C Technologies announces a research collaboration with Sandia National Laboratories' Center for Integrated Nanotechnologies to advance its optical processing unit (OPU) initiative aimed at enhancing AI inference through nanophotonics. This partnership leverages Sandia’s extensive expertise in photonics and nanoscale technologies to develop scalab…

AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video

AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video

AIM ImmunoTech discusses the potential of its drug Ampligen® to complement new pancreatic cancer treatments by enhancing the innate immune response. Encouraging survival data from a Dutch Named Patient Program and an ongoing Phase 2 DURIPANC study investigating Ampligen in combination with AstraZeneca's durvalumab support further clinical developme…

Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND

Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND

Ernexa Therapeutics announced positive results from three key IND-enabling safety studies of ERNA-101, its lead cell therapy for ovarian cancer. The repeat-dose GLP toxicology study revealed no adverse findings at any dose, the tumorigenicity study showed no teratoma formation over six months, and biodistribution analysis confirmed targeted tumor d…

Rich Sparkle Holdings Limited Announces Unaudited Financial Results For The Six Months Ended March 31, 2026

Rich Sparkle Holdings Limited Announces Unaudited Financial Results For The Six Months Ended March 31, 2026

Rich Sparkle Holdings Limited announced a 21.8% increase in revenue for the six months ended March 31, 2026, driven by growth in financial printing and advisory services. Despite this growth, the company recorded a significant net loss of over $39 million, primarily due to a $38.85 million share-based compensation expense linked to equity incentive…

SKYX Signs Agreement to Supply Its Safe-Advanced & Smart Technologies to Trump Towers Landmark Luxury Development in Hyderabad, India, One of India’s Leading Tech Hubs

SKYX Signs Agreement to Supply Its Safe-Advanced & Smart Technologies to Trump Towers Landmark Luxury Development in Hyderabad, India, One of India’s Leading Tech Hubs

SKYX Platforms Corp., a U.S.-based technology company specializing in advanced safe and smart home technologies, announced an agreement to supply its patented systems to Trump Towers Hyderabad, a large luxury residential development in one of India's leading tech hubs. The project, featuring two 65-storey towers with over 450 residences, highlights…

Trump Media & Technology Group and TAE Technologies File Form S-4 Registration Statement for Proposed Merger

Trump Media & Technology Group and TAE Technologies File Form S-4 Registration Statement for Proposed Merger

Trump Media & Technology Group Corp. (DJT) and TAE Technologies have filed a Form S-4 registration statement with the SEC for a proposed all-stock merger, aiming to create a publicly traded company focused on commercial fusion energy and advanced technology commercialization. Upon completion, shareholders of both companies will equally own the comb…

Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)

Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)

Lantheus Holdings announced that the Centers for Medicare & Medicaid Services (CMS) granted Transitional Pass-Through (TPT) payment status for their new PSMA-targeted PET imaging agent, PYLARIFY TruVu, effective October 1, 2026. This status enables separate reimbursement in the hospital outpatient setting, facilitating broader patient access. The c…

PowerCompute Repays Arch Bitcoin-Backed Facility, Releases All Bitcoin Collateral and Achieves Approximately 94% Reduction in Total Debt

PowerCompute Repays Arch Bitcoin-Backed Facility, Releases All Bitcoin Collateral and Achieves Approximately 94% Reduction in Total Debt

PowerCompute, Inc. has fully repaid its $22.45 million Bitcoin-backed credit facility with Arch Lending, eliminating all Bitcoin collateral and reducing total secured debt by approximately 94%. The company returned about 39.6 Bitcoins to its holdings and significantly lowered interest expenses. PowerCompute now plans to use capital to expand Bitcoi…

Elmet Technologies Awarded $36 Million Defense Logistics Agency Contract for Molybdenum and Tungsten Aerospace Materials

Elmet Technologies Awarded $36 Million Defense Logistics Agency Contract for Molybdenum and Tungsten Aerospace Materials

The Elmet Group's wholly owned subsidiary, Elmet Technologies, has been awarded a $36 million contract by the Defense Logistics Agency to supply high-performance molybdenum and tungsten alloys and precision wire used in jet engine components and aerospace applications. This award builds on a prior $2 billion DLA tungsten contract and further streng…

Skyward Group Expands ibott’s Next-Generation Autonomous Vehicle Solutions Into U.S. Primary Market

Skyward Group Expands ibott’s Next-Generation Autonomous Vehicle Solutions Into U.S. Primary Market

Skyward Group announces the expansion of its ibott subsidiary's autonomous vehicle insurance expertise into the U.S. primary insurance market, offering a comprehensive suite of innovative insurance products tailored to the evolving risks in the autonomous vehicle ecosystem. Leveraging deep industry expertise, data-driven approaches, and Skyward's b…

SEALSQ Highlights Its Subsidiary IC’Alps’ Low-Power, Secure ASIC Design Expertise for Implantable and Connected Medical Devices

SEALSQ Highlights Its Subsidiary IC’Alps’ Low-Power, Secure ASIC Design Expertise for Implantable and Connected Medical Devices

SEALSQ Corp, a US-listed company specializing in semiconductors and post-quantum cybersecurity, emphasizes the capabilities of its French subsidiary IC'Alps in designing custom, low-power, secure ASICs tailored for implantable and connected medical devices. The acquisition strengthens SEALSQ's position in the growing medical electronics market by c…

Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer

Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer

Candel Therapeutics disclosed novel data from phase 2 and phase 3 trials showing that aglatimagene besadenovec, combined with external beam radiation therapy, induces durable local and systemic immune activation in intermediate-risk localized prostate cancer. The phase 3 trial demonstrated significant reductions in risk of recurrence and metastasis…

Battalion Oil Announces Publication of Updated Investor Presentation

Battalion Oil Announces Publication of Updated Investor Presentation

Battalion Oil Corporation announced the release of its updated September 2026 investor presentation, detailing its strategic priorities, Delaware Basin asset portfolio, financial position, and outlook through 2027. The company highlighted its balance-sheet improvements, capital-efficient growth plans, and commitment to transparent investor communic…